Zhejiang Starry Pharmaceutical Co.,Ltd.

Shanghai Stock Exchange 603520.SS

Zhejiang Starry Pharmaceutical Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 79.60 M

Zhejiang Starry Pharmaceutical Co.,Ltd. Cash and Short-Term Investments is USD 79.60 M for the year ending December 31, 2023, a -17.08% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Zhejiang Starry Pharmaceutical Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 95.99 M, a -27.89% change year over year.
Zhejiang Starry Pharmaceutical Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 133.13 M, a -6.59% change year over year.
Zhejiang Starry Pharmaceutical Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 142.51 M, a 128.78% change year over year.
Zhejiang Starry Pharmaceutical Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 62.29 M, a 128.95% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Shanghai Stock Exchange: 603520.SS

Zhejiang Starry Pharmaceutical Co.,Ltd.

CEO	Mr. Weiyi Shen
IPO Date	March 9, 2016
Location	China
Headquarters	Xianju modern industrial cluster
Employees	1,845
Sector	Health Care
Industries Pharmaceuticals Cosmetics

Description

Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products comprise levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is based in Xianju, China.

Key trends

Past 5 years